期刊文献+

解毒养阴方结合IMRT治疗局部晚期鼻咽癌临床观察

Combination of “Jiedu Yangyin Formula ” and IMRT for the treatment of advanced nasopharyngeal carcinoma
原文传递
导出
摘要 目的观察解毒养阴方结合IMRT治疗局部晚期鼻咽癌的临床疗效。方法将100例晚期鼻咽癌患者随机分为对照组与观察组,各50例;两组均给予全程IMRT治疗,观察组在对照组基础上给予解毒养阴方治疗,疗程8周。观察两组短期临床疗效、放疗剂量和毒副反应发生情况。结果观察组显效率为84.0%,对照组为54.0%,观察组疗效明显优于对照组(P<0.01);观察组的放疗剂量小于对照组(P<0.05);观察组毒副反应发生率为40.0%,对照组为30.0%,观察组毒副反应发生率低于对照组(P<0.05)。结论解毒养阴方结合IMRT治疗局部晚期鼻咽癌的临床疗效良好,且能减少放疗剂量,减轻毒副反应。 Objective To observed the clinicalefficacy of "Jiedu Yangyin Formula" and IMRT in treating advanced nasopharyngeal carcinoma, Methods One hundred cases with advanced nasopharyngeal carcinoma were randomly divided into observation group and control group, with 50 cases in each group. Both groups were treated by IMRT, and observation group was treated by "Jiedu Yangyin Formula" additionally, with the course of 8 weeks. The short-term efficacy, radiation dose, adverse reactions were observed in both groups. Results The obvious effective rate was 84.0% in the observation group and was 54.0% in the control group, with significant difference between the two groups ( P 〈 0.01 ) ; the radiation dose of the observation group was less than that of the control group (P 〈 0.05 ) ; the occurrence rate was 40.0% in the observation group and was 30.0% in the control group, with significant difference between the two groups ( P 〈 0.05 ). Conclusion Combined "Jiedu Yangyin Formula" and IMRT has good therapeutic effects on advanced nasopharyngeal carcinoma, and can decrease the radiation dose and alleviate adverse effects.
作者 杨志勇 万鸿
出处 《上海中医药杂志》 2014年第10期31-32,共2页 Shanghai Journal of Traditional Chinese Medicine
关键词 晚期鼻咽癌 IMRT 解毒养阴方 放疗剂量 毒副反应 advanced nasopharyngeal carcinoma IMRT "Jiedu Yangyin Formula" radiation dose adverse reaction
  • 相关文献

参考文献5

二级参考文献25

  • 1吴式琇,张萍,谢聪颖,金献测.鼻咽癌调强放射治疗的临床研究[J].中华放射肿瘤学杂志,2004,13(3):154-157. 被引量:28
  • 2王树森,管忠震,向燕群,汪波,林桐榆,姜文奇,张力,张惠忠,侯景辉.鼻咽癌组织中EGFR和p-ERK蛋白表达的检测及意义[J].中华肿瘤杂志,2006,28(1):28-31. 被引量:47
  • 3黄晓东,易俊林,高黎,徐国镇,金晶,杨伟志,卢泰祥,吴少雄,吴仁瑞,胡伟汉,谢伟长,韩非,高远红,高剑铭,潘建基,陈传本,朗锦义,李涛,董昱,付玉彬,樊林,李柏森,黎静,王晓怀,陈炳旭,高献书,张萍,吴湘玮,胡炳强.抗表皮生长因子受体单克隆抗体h—R3联合放疗治疗晚期鼻咽癌的Ⅱ期临床研究[J].中华肿瘤杂志,2007,29(3):197-201. 被引量:100
  • 4胡巧英,刘鹏,王磊,付真富.Ⅲ、Ⅳ a期鼻咽癌患者放疗同期化疗加辅助化疗的疗效[J].癌症,2007,26(4):394-397. 被引量:43
  • 5Leibel SA,Kutcher GJ,Harrison LB,et al.Improved dose in distributionfor 3D conformal boost treatment in carcinoma of the nasopharynx[J].Int J Radiat oncol Biol Phys,1991,20(4):823-833.
  • 6MODJTAHEDI H, ESSAPEN S. Epidermal growth factor receptorinhibitors in cancer treatment: advances, challenges and opportu- nities[ J]. Anticancer Drugs, 2009, 20(10) : 851 -855.
  • 7TALAVERA A, FRIEMANN R, GOMEZ PUERTA S, et al. Nimo- tuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks lig and binding while permitting the active receptor conformation[ J]. Cancer Res, 2009, 69 ( 14 ) : 5851 - 5859.
  • 8HE X Y, HU C S, YING H M, et al. Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma[ J ]. Eur Arch Otorhinolaryngol, 2010, 267 (5) : 773 - 778.
  • 9SUNDVALL M, KARRILA A, NORDBERG J. EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma [J]. Expert Opin Emerg Drugs, 2010, 15(2): lS5 -201.
  • 10LOEFFLER RAGG J, SCHWENTNER I, SPRINZL G M, et al. EG- FR inhibition as a therapy for head and neck squamous cell carcinoma [j]. Expert Opin Investig Drugs, 2008, 17(10): 1517-1531.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部